An Invivo Study to Compare the Stability of Dental Implants With or Without Platelet Rich Fibrin Application
The Effect Of Platelet Rich Fibrin on Implant Stability
1 other identifier
interventional
20
1 country
1
Brief Summary
The purpose of this study was to evaluate the effects of (Platelet Rich Fibrin) PRF application on implant osseointegration in the early phase of healing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 8, 2014
CompletedFirst Posted
Study publicly available on registry
July 15, 2014
CompletedJuly 15, 2014
July 1, 2014
1 month
July 8, 2014
July 14, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Implant Stabilitty Quotient (ISQ) evaluation: analysis of the resonance frequency values 4 week period.
The stability of the implants were evaluated with the resonance frequency analysis (RFA) method. The measurements were carried out with Osstell ISQ (Implant Stability Quotient) (Osstell, Göteborg, Sweden) by connecting the transducer (smartpeg) to the implant. Two mesio-distal and bucco-lingual measurements were recorded and mean ISQ values were calculated. The resonance frequency measurements were repeated at first and fourth weeks.
Resonance frequency measurements were made by Osstell ISQ after placement of implants, at 1 week and one month postoperatively.
Secondary Outcomes (1)
Evaluation of osseointegration in different types of bone
Resonance frequency measurements in different bone types were made by Osstell ISQ after placement of implants, at 1 week and one month postoperatively.
Study Arms (1)
Test, Control
EXPERIMENTALTest: Minimum two tapered implants (Ankylosis, Dentsply Friadent) were placed to each patient. After surgical preparation of implant sockets, PRF that was prepared preoperatively was placed randomly to one of the sockets (PRF+). Acellular plasma portion of PRF was used to wet the implant placed into the PRF-coated socket Control: Other socket was selected as a control group (No Platelet Rich Fibrin used): In the control group no extra intervention used and the conventional procedure was done. Thus the readings of the experimental arm compared with this control.
Interventions
This longitudinal human clinical trial is designed to measure implant stability with the resonance frequency analyzer (Osstell, Integration Diagnostics AB, Sweden) at time of implant placement and up to 4 weeks post placement. delivered. No further follow-up will be done with the resonance frequency approach
Eligibility Criteria
You may qualify if:
- The absence of any lesions in the oral cavity, and sufficient residual bone volume to receive two or more adjacent implants of ≥3.5 mm in diameter and 11.0 mm in length, and extracted at least 6 months ago.
You may not qualify if:
- Insufficient bone volume
- Parafunctional habits
- Smoking more than 10 cigarettes per day
- Excessive consumption of alcohol
- Localized radiotherapy of the oral cavity
- Antitumor chemotherapy
- Liver, blood, and kidney diseases
- Immunosuppression
- Current corticosteroid or bisphosphonate use
- Pregnancy
- Mucocutaneous diseases involving oral cavity
- Poor oral hygiene
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ELİF ONCUlead
- Baskent Universitycollaborator
Study Sites (1)
NECMETTIN ERBAKAN University Faculty of Dentistry, Department of Periodontology,
Ankara, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
ELİF ÖNCÜ, 1
NECMETTİN ERBAKAN UNIVERSITY
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assist.Prof.Dr.
Study Record Dates
First Submitted
July 8, 2014
First Posted
July 15, 2014
Study Start
December 1, 2011
Primary Completion
January 1, 2012
Study Completion
December 1, 2012
Last Updated
July 15, 2014
Record last verified: 2014-07